4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001610717-25-000258
Options or other derivatives
- Director acquired 5,860 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Scopa James Paul Director | 2025-06-25 | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | D | ||
Loading xslF345X05/form4.xml…